Initiation of dosing in our Phase 1b clinical trial represents an important step in the clinical development of GT-02287 and in Gain’s mission to deliver a disease-modifying therapy to people with ...
Thor Industries (NYSE: THO) stock closed Monday trading below $100, but one analyst thinks it could be worth a lot more than ...